Mundipharma benefits from an array of international research, which drives our provision of innovative healthcare products that enables Australians to live well and age well.

Mundipharma’s global research concentrates on three therapeutic areas: pain, oncology and respiratory diseases. R&D is managed by two independent associated companies, Mundipharma Research Limited in Cambridge, United Kingdom, and Mundipharma Research GmbH in Limburg, Germany, which are dedicated to developing only the most effective and innovative medications. Through these companies, Mundipharma works on pre-clinical research, pharmaceutical development, clinical development, drug safety, regulatory affairs and scientific support of new therapeutic products.

Mundipharma is constantly on the lookout for substances that offer better therapeutic options for patients, which will not only help treat their conditions but will also improve their quality of life.